No Data
No Data
Cyclacel Receives Grant Of European Patent EP4013503 Titled "Crystalline Forms Of Pyrimidino Diazepine Derivative For The Treatment Of Tumors"
Cyclacel Pharmaceuticals GAAP EPS of -$0.72
Roth MKM Maintains Cyclacel Pharmaceuticals(CYCC.US) With Buy Rating, Maintains Target Price $11
Analysts Conflicted on These Healthcare Names: Abeona Therapeutics (ABEO), Cyclacel Pharmaceuticals (CYCC) and Cardinal Health (CAH)
10-Q: Quarterly report
Express News | Cyclacel Pharmaceuticals Q2 2024 GAAP EPS $(0.72) Beats $(1.44) Estimate, Sales $4.00K Miss $30.00K Estimate